Universe Pharmaceutical Class AUPC
13F holders, Q1 2025 (March 31)1holders
$4.10avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding Universe Pharmaceutical Class A (UPC) in their 13F filings. The largest holder was UBS Group AG ($1K).
- Company
- Universe Pharmaceutical Class A
- CUSIP
- G9442G138
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $1K |
| Exits | 0 | $0 |
Ownership 1 holders
| UBS Group AG | 0.00% | New | 266 | $1K |
"% of holder's portfolio" is UPC's weight in each manager's 13F, not the share of Universe Pharmaceutical Class A the manager owns.